Altaris Acquires Clarivate Life Sciences & Healthcare Segment

July 6, 2026

Clarivate agreed to sell its Life Sciences & Healthcare segment to Altaris for $600 million, with proceeds intended in part to reduce Clarivate’s debt. The transaction was completed on October 6, 2026, and the business will operate independently under Altaris ownership.

Buyers
Altaris LLC
Targets
Clarivate Life Sciences & Healthcare segment
Sellers
Clarivate plc
Industry
Data & Analytics
Location
Pennsylvania, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.